Fiche centre
Stollery Children's Hospital
Edmonton — Canada
Essais liés4clinical trials
VilleEdmontonlocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03938987
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Lorcaserin | Épilepsie | À vérifier | NCT04457687 | Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies | NO_LONGER_AVAILABLE |
| autologous CD19-directed chimeric antigen receptor (CAR) T-cells | SEP | Phase 1/2 | NCT03938987 | ACIT001/EXC002 — Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | ACTIVE_NOT_RECRUITING |
| Lung Volume Recruitment (LVR) | Myopathies | Phase 4 | NCT01999075 | STEADFAST — Stacking Exercises Aid the Decline in FVC and Sick Time | COMPLETED |